PHARMACYTE BIOTECH, INC. Treasury Stock, Value
PHARMACYTE BIOTECH, INC. (PMCB) had Treasury Stock, Value of $40.28 million as of 2023-07-31, per its 10-Q filed 2024-09-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2024-09-17
- 2023-07-31: Treasury Stock, Value $40.28M.
- 2023-01-31: Treasury Stock, Value $9.25M.
- 2022-10-31: Treasury Stock, Value $5.48M.
- 2022-07-31: Treasury Stock, Value $2.09M.
| Period end | Treasury Stock, Value |
|---|---|
| 2023-07-31 | $40.28M 10-Q · filed 2024-09-17 |
| 2023-01-31 | $9.25M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $5.48M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $2.09M 10-Q · filed 2022-09-14 |
| 2022-04-30 | $0.00 10-Q · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |